CPT1A expression was found to be closely related to a poor prognosis in prostate cancer, ovarian cancer, Burkitt’s lymphoma, glioblastoma, leukemia, breast cancer, and gastric cancer [20]. This evidence concerns the gene CPT1A and breast carcinoma.